Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 802, pseudogene (RN7SL802P)

Target
RN7SL802P
Molecular classification
Other, non-coding RNA pseudogene
01

Overview

RN7SL802P is a pseudogene corresponding to the 7SL RNA, a highly conserved non-coding RNA that forms the RNA backbone of the signal recognition particle (SRP), a ribonucleoprotein complex required for targeting secretory proteins to the endoplasmic reticulum in eukaryotes. The human genome contains hundreds of 7SL RNA pseudogenes, which are typically truncated, non-functional copies resulting from retrotransposition events. Pseudogenes like RN7SL802P are generally considered "genomic fossils" and do not produce a functional product, nor are they targets for drugs or disease intervention. While some pseudogenes can regulate gene expression of their parent gene through RNA-mediated mechanisms, this is not established for RN7SL802P. No drugs, biomarkers, or disease associations are documented for this pseudogene. This entry is a non-coding RNA pseudogene and not an active therapeutic target. It does not encode a protein or act as a receptor, enzyme, transporter, or transcription factor. No known roles in disease, biomarker use, or drug interaction. No safety concerns or therapeutic relevance. The provided name and abbreviation are correct; the entry is simply not a viable drug target based on current knowledge.

Other names
RN7SL802P7SL RNA pseudogene 8027SL cytoplasmic pseudogene 802
02

Biological functions

Most pseudogenes, including RN7SL802P, are not known to encode functional molecules.In rare cases, pseudogene RNAs may regulate their parental gene's expression via RNA-based mechanisms (e.g., acting as competitive endogenous RNAs), but there is no evidence this particular pseudogene has a functional role.
03

Disease associations

None established for RN7SL802P specifically.Pseudogenes in general can sometimes be implicated in cancer, but there is no literature for RN7SL802P.

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 802, pseudogene (RN7SL802P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 802, pseudogene (RN7SL802P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call